The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Glia: Initiators and progressors of pathology in Parkinson's disease
Abstract
Background: Glia are traditionally known as support cells for neurons, and their role in neurodegeneration has been largely considered secondary to neuronal dysfunction. We review newer concepts on glial function and assess glial changes in Parkinson's disease (PD) at the time of disease initiation when α‐synuclein is accumulating in brain tissue but there is limited neuronal loss, and also as the disease progresses and neuronal loss is evident. Results: Of the two main types of astrocytes, only protoplasmic astrocytes are involved in PD, where they become nonreactive and accumulate α‐synuclein. Experimental evidence has shown that astrocytic α‐synuclein deposition initiates the noncell autonomous killing of neurons through microglial signaling. As the disease progresses, more protoplasmic astrocytes are affected by the disease with an increasing microglial response. Although there is still controversy on the role microglia play in neurodegeneration, there is evidence that microglia are activated early in PD and possibly assist with the clearance of extracellular α‐synuclein at this time. Microglia transform to phagocytes and target neurons as the disease progresses but appear to become dysfunctional with increasing amounts of ingested debris. Only nonmyelinating oligodendroglial cells are affected in PD, and only late in the disease process. Conclusions: Glial cells are responsible for the progression of PD and play an important role in initiating the early tissue response. In particular, early dysfunction and α‐synuclein accumulation in astrocytes causes recruitment of phagocytic microglia that attack selected neurons in restricted brain regions causing the clinical symptoms of PD. © 2011 Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827
Astrocytes: Biology and pathology
Sofroniew, M. V., & Vinters, H. V. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0619-8 · Cited by 5,196
Microglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396
ATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913
AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITY
FEARNLEY, J. M., & LEES, A. J. (1991) · Brain · doi:10.1093/brain/114.5.2283 · Cited by 3,529
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Vane, J. R., Bakhle, Y. S., & Botting, R. M. (1998) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.97 · Cited by 2,734
Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain
Lawson, L. J., Perry, V. H., Dri, P., & Gordon, S. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90229-w · Cited by 2,045
Neuroinflammation in Parkinson’s disease: A target for neuroprotection?
Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984
Li, J.-Y., Englund, E., Holton, J. L., Soulet, D., Hagell, P., Lees, A. J., Lashley, T., Quinn, N. P., Rehncrona, S., Björklund, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1746 · Cited by 1,845
Biology of Oligodendrocyte and Myelin in the Mammalian Central Nervous System
Baumann, N., & Pham-Dinh, D. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.871 · Cited by 1,828
Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease
Kordower, J. H., Chu, Y., Hauser, R. A., Freeman, T. B., & Olanow, C. W. (2008) · Nature Medicine · doi:10.1038/nm1747 · Cited by 1,722
Braak, H., R�b, U., Gai, W. P., & Del Tredici, K. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0808-2 · Cited by 1,683
Wake, H., Moorhouse, A. J., Jinno, S., Kohsaka, S., & Nabekura, J. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4363-08.2009 · Cited by 1,619
Uniquely Hominid Features of Adult Human Astrocytes
Oberheim, N. A., Takano, T., Han, X., He, W., Lin, J. H. C., Wang, F., Xu, Q., Wyatt, J. D., Pilcher, W., Ojemann, J. G., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4707-08.2009 · Cited by 1,488
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., & Lee, S.-J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903691106 · Cited by 1,485
Microglia-specific localisation of a novel calcium binding protein, Iba1
Ito, D., Imai, Y., Ohsawa, K., Nakajima, K., Fukuuchi, Y., & Kohsaka, S. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00040-0 · Cited by 1,476
The Mystery and Magic of Glia: A Perspective on Their Roles in Health and Disease
Barres, B. A. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.013 · Cited by 1,352
Zhang, W., Wang, T., Pei, Z., Miller, D. S., Wu, X., Block, M. L., Wilson, B., Zhang, W., Zhou, Y., Hong, J.-S., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-2751com · Cited by 1,265
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
Gerhard, A., Pavese, N., Hotton, G., Turkheimer, F., Es, M., Hammers, A., Eggert, K., Oertel, W., Banati, R. B., & Brooks, D. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.002 · Cited by 1,200
Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183
Brochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36470 · Cited by 1,172
Activated microglia mediate neuronal cell injury via a nitric oxide mechanism
Chao, C. C., Hu, S., Molitor, T. W., Shaskan, E. G., & Peterson, P. K. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.8.2736 · Cited by 1,136
Liu, B., & Hong, J.-S. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035048 · Cited by 1,095
Liberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M., & Przedborski, S. (1999) · Nature Medicine · doi:10.1038/70978 · Cited by 1,046 · cited 1×
“6-hydroxydopamine animal models and in MPTP mice lacking the iNOS gene.(88) Increased concentrations of the proinflammatory cytokines have been identified in the striatum, SN,(112) serum, and cerebrospinal fluid in patients with PD.”
BackgroundParkinson's disease: a dual‐hit hypothesis
Hawkes, C. H., Del Tredici, K., & Braak, H. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00874.x · Cited by 1,021
Mogi, M., Harada, M., Riederer, P., Narabayashi, H., Fujita, K., & Nagatsu, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90746-3 · Cited by 986
Description of Parkinson's Disease as a Clinical Syndrome
FAHN, S. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07458.x · Cited by 977
Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death
Boje, K. M., & Arora, P. K. (1992) · Brain Research · doi:10.1016/0006-8993(92)91004-x · Cited by 944
Lee, H.-J., Suk, J.-E., Patrick, C., Bae, E.-J., Cho, J.-H., Rho, S., Hwang, D., Masliah, E., & Lee, S.-J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.081125 · Cited by 877
Imai, Y., Ibata, I., Ito, D., Ohsawa, K., & Kohsaka, S. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1112 · Cited by 872
Mogi, M., Harada, M., Kondo, T., Riederer, P., Inagaki, H., Minami, M., & Nagatsu, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90508-8 · Cited by 855
Microglial activation and dopamine terminal loss in early Parkinson's disease
Ouchi, Y., Yoshikawa, E., Sekine, Y., Futatsubashi, M., Kanno, T., Ogusu, T., & Torizuka, T. (2005) · Annals of Neurology · doi:10.1002/ana.20338 · Cited by 843
Blum-Degena, D., Müller, T., Kuhn, W., Gerlach, M., Przuntek, H., & Riederer, P. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12192-7 · Cited by 801
Imamura, K., Hishikawa, N., Sawada, M., Nagatsu, T., Yoshida, M., & Hashizume, Y. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0766-2 · Cited by 791
Integrated Brain Circuits: Astrocytic Networks Modulate Neuronal Activity and Behavior
Halassa, M. M., & Haydon, P. G. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135843 · Cited by 763
Microglia: biology and pathology
Graeber, M. B., & Streit, W. J. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0622-0 · Cited by 725
Glial reactions in Parkinson's disease
McGeer, P. L., & McGeer, E. G. (2008) · Movement Disorders · doi:10.1002/mds.21751 · Cited by 701
Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration
Teismann, P., Tieu, K., Choi, D.-K., Wu, D.-C., Naini, A., Hunot, S., Vila, M., Jackson-Lewis, V., & Przedborski, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0837397100 · Cited by 660
Wu, D.-C., Teismann, P., Tieu, K., Vila, M., Jackson-Lewis, V., Ischiropoulos, H., & Przedborski, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0937239100 · Cited by 633
Nitric oxide synthase and neuronal vulnerability in parkinson's disease
Hunot, S., Boissière, F., Faucheux, B., Brugg, B., Mouatt-Prigent, A., Agid, Y., & Hirsch, E. C. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00578-1 · Cited by 595
Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease
Boka, G., Anglade, P., Wallach, D., Javoy-Agid, F., Agid, Y., & Hirsch, E. C. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90684-x · Cited by 590
Rate of cell death in parkinsonism indicates active neuropathological process
McGeer, P. L., Itagaki, S., Akiyama, H., & McGeer, E. G. (1988) · Annals of Neurology · doi:10.1002/ana.410240415 · Cited by 556
Inflammatory Regulators in Parkinson's Disease: iNOS, Lipocortin-1, and Cyclooxygenases-1 and -2
Knott, C., Stern, G., & Wilkin, G. P. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0914 · Cited by 503
The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease
Bandopadhyay, R. (2004) · Brain · doi:10.1093/brain/awh054 · Cited by 468
Braak, H., Sastre, M., & Del Tredici, K. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0244-3 · Cited by 462
Astrocytes and the regulation of cerebral blood flow
Koehler, R. C., Roman, R. J., & Harder, D. R. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.11.005 · Cited by 444
Wakabayashi, K., Hayashi, S., Yoshimoto, M., Kudo, H., & Takahashi, H. (2000) · Acta Neuropathologica · doi:10.1007/pl00007400 · Cited by 441
Glial pathology but absence of apoptotic nigral neurons in long‐standing Parkinson's disease
Banati, R. B., Daniel, S. E., & Blunt, S. B. (1998) · Movement Disorders · doi:10.1002/mds.870130205 · Cited by 431
Hunot, S., Vila, M., Teismann, P., Davis, R. J., Hirsch, E. C., Przedborski, S., Rakic, P., & Flavell, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307453101 · Cited by 426
Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson’s disease
Reynolds, A. D., Banerjee, R., Liu, J., Gendelman, H. E., & Lee Mosley, R. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0507296 · Cited by 420
Croisier, E., Moran, L. B., Dexter, D. T., Pearce, R. K., & Graeber, M. B. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-14 · Cited by 414
Inflammatory Process in Parkinsons Disease: Role for Cytokines
Nagatsu, T., & Sawada, M. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053381620 · Cited by 412
Cicchetti, F., Brownell, A. L., Williams, K., Chen, Y. I., Livni, E., & Isacson, O. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.01938.x · Cited by 406
The origin and cell lineage of microglia: new concepts
Chan, W. Y., Kohsaka, S., & Rezaie, P. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.11.002 · Cited by 400
McGeer, P. L., Schwab, C., Parent, A., & Doudet, D. (2003) · Annals of Neurology · doi:10.1002/ana.10728 · Cited by 400
Microglial senescence: does the brain's immune system have an expiration date?
Streit, W. J. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.07.001 · Cited by 397
Evidence that incidental Lewy body disease is pre-symptomatic Parkinson’s disease
Dickson, D. W., Fujishiro, H., DelleDonne, A., Menke, J., Ahmed, Z., Klos, K. J., Josephs, K. A., Frigerio, R., Burnett, M., Parisi, J. E., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0345-7 · Cited by 364
Greffard, S., Verny, M., Bonnet, A.-M., Beinis, J.-Y., Gallinari, C., Meaume, S., Piette, F., Hauw, J.-J., & Duyckaerts, C. (2006) · Archives of Neurology · doi:10.1001/archneur.63.4.584 · Cited by 354
A possible role for humoral immunity in the pathogenesis of Parkinson's disease
Orr, C. F., Rowe, D. B., Mizuno, Y., Mori, H., & Halliday, G. M. (2005) · Brain · doi:10.1093/brain/awh625 · Cited by 350
Self-citationClearance and deposition of extracellular α-synuclein aggregates in microglia
Lee, H.-J., Suk, J.-E., Bae, E.-J., & Lee, S.-J. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.05.045 · Cited by 343
PINK1 protein in normal human brain and Parkinson's disease
Gandhi, S. (2006) · Brain · doi:10.1093/brain/awl114 · Cited by 342
Gu, X.-L., Long, C.-X., Sun, L., Xie, C., Lin, X., & Cai, H. (2010) · Molecular Brain · doi:10.1186/1756-6606-3-12 · Cited by 340
Research in motion: the enigma of Parkinson's disease pathology spread
Brundin, P., Li, J.-Y., Holton, J. L., Lindvall, O., & Revesz, T. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2477 · Cited by 328
Mirza, B., Hadberg, H., Thomsen, P., & Moos, T. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00455-8 · Cited by 327
Parkin Localizes to the Lewy Bodies of Parkinson Disease and Dementia with Lewy Bodies
Schlossmacher, M. G., Frosch, M. P., Gai, W. P., Medina, M., Sharma, N., Forno, L., Ochiishi, T., Shimura, H., Sharon, R., Hattori, N., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61113-3 · Cited by 325
Association of circulating TNF-α and IL-6 with ageing and parkinsonism
Dobbs, R. J., Charlett, A., Purkiss, A. G., Dobbs, S. M., Weller, C., & Peterson, D. W. (1999) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1999.tb00721.x · Cited by 324
Selective microglial activation in the rat rotenone model of Parkinson's disease
Sherer, T. B., Betarbet, R., Kim, J.-H., & Greenamyre, J. T. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00172-1 · Cited by 316
Teismann, P., & Ferger, B. (2001) · Synapse · doi:10.1002/1098-2396(200102)39:2<167::aid-syn8>3.0.co;2-u · Cited by 306
A one-hit model of cell death in inherited neuronal degenerations
Clarke, G., Collins, R. A., Leavitt, B. R., Andrews, D. F., Hayden, M. R., Lumsden, C. J., & McInnes, R. R. (2000) · Nature · doi:10.1038/35018098 · Cited by 303
Yazawa, I., Giasson, B. I., Sasaki, R., Zhang, B., Joyce, S., Uryu, K., Trojanowski, J. Q., & Lee, V. M.-Y. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.032 · Cited by 301
Neuroanatomy and Pathology of Sporadic Parkinson's Disease
(2008) · Advances in Anatomy, Embryology and Cell Biology · doi:10.1007/978-3-540-79850-7 · Cited by 297
The influence of microglia on the pathogenesis of Parkinson's disease
Long-Smith, C. M., Sullivan, A. M., & Nolan, Y. M. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.08.001 · Cited by 296
Streit, W. J., Graeber, M. B., & Kreutzberg, G. W. (1989) · Experimental Neurology · doi:10.1016/0014-4886(89)90111-8 · Cited by 287
Mogi, M., Togari, A., Kondo, T., Mizuno, Y., Komure, O., Kuno, S., Ichinose, H., & Nagatsu, T. (2000) · Journal of Neural Transmission · doi:10.1007/s007020050028 · Cited by 282
Choi, D.-K., Pennathur, S., Perier, C., Tieu, K., Teismann, P., Wu, D.-C., Jackson-Lewis, V., Vila, M., Vonsattel, J.-P., Heinecke, J. W., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0970-05.2005 · Cited by 282
Lipocalin-2 Is an Autocrine Mediator of Reactive Astrocytosis
Lee, S., Park, J.-Y., Lee, W.-H., Kim, H., Park, H.-C., Mori, K., & Suk, K. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5273-08.2009 · Cited by 280
Rogers, J., Mastroeni, D., Leonard, B., Joyce, J., & Grover, A. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(07)82012-5 · Cited by 260
Nandhagopal, R., Kuramoto, L., Schulzer, M., Mak, E., Cragg, J., Lee, C. S., McKenzie, J., McCormick, S., Samii, A., Troiano, A., et al. (2009) · Brain · doi:10.1093/brain/awp209 · Cited by 259
Patterns and stages of α-synucleinopathy: Relevance in a population-based cohort
Zaccai, J., Brayne, C., McKeith, I., Matthews, F., & Ince, P. G. (2008) · Neurology · doi:10.1212/01.wnl.0000306697.48738.b6 · Cited by 244
Song, Y. J. C., Halliday, G. M., Holton, J. L., Lashley, T., O'Sullivan, S. S., McCann, H., Lees, A. J., Ozawa, T., Williams, D. R., Lockhart, P. J., et al. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181b66f1b · Cited by 241
Self-citationLewy bodies in Parkinson's disease are recognized by antibodies to complement proteins
Yamada, T., McGeer, P. L., & McGeer, E. G. (1992) · Acta Neuropathologica · doi:10.1007/bf00427222 · Cited by 231
Rodriguez‐Pallares, J., Parga, J. A., Muñoz, A., Rey, P., Guerra, M. J., & Labandeira‐Garcia, J. L. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04699.x · Cited by 231
Sánchez‐Pernaute, R., Ferree, A. W., Cooper, O., Yu, M., Brownell, A., & Ole Isacson, A. (2004) · Journal of Neuroinflammation · doi:10.1186/1742-2094-1-6 · Cited by 211
Faissner, A., Pyka, M., Geissler, M., Sobik, T., Frischknecht, R., Gundelfinger, E. D., & Seidenbecher, C. (2010) · Brain Research Reviews · doi:10.1016/j.brainresrev.2010.01.001 · Cited by 207
Barcia, C., Bahillo, A. S., Fernández‐Villalba, E., Bautista, V., Poza Y Poza, M., Fernández‐Barreiro, A., Hirsch, E. C., & Herrero, M. (2004) · Glia · doi:10.1002/glia.20015 · Cited by 206
Zecca, L., Wilms, H., Geick, S., Claasen, J.-H., Brandenburg, L.-O., Holzknecht, C., Panizza, M. L., Zucca, F. A., Deuschl, G., Sievers, J., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0361-7 · Cited by 205
Nitrated α-Synuclein-Induced Alterations in Microglial Immunity Are Regulated by CD4+ T Cell Subsets
Reynolds, A. D., Stone, D. K., Mosley, R. L., & Gendelman, H. E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803982 · Cited by 197
Müller, T., Blum-Degen, D., Przuntek, H., & Kuhn, W. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1998.tb01736.x · Cited by 195
Streit, W. J., Graeber, M. B., & Kreutzberg, G. W. (1989) · Journal of Neuroimmunology · doi:10.1016/0165-5728(89)90167-7 · Cited by 185
LRRK2 Expression in Normal and Pathologic Human Brain and in Human Cell Lines
Miklossy, J., Arai, T., Guo, J.-P., Klegeris, A., Yu, S., McGeer, E. G., & McGeer, P. L. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000235121.98052.54 · Cited by 182
Poor and protracted myelination as a contributory factor to neurodegenerative disorders
Braak, H., & Del Tredici, K. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.04.001 · Cited by 178
β-Synuclein gene alterations in dementia with Lewy bodies
Ohtake, H., Limprasert, P., Fan, Y., Onodera, O., Kakita, A., Takahashi, H., Bonner, L. T., Tsuang, D. W., Murray, I. V. J., Lee, V. M.-Y., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000139870.14385.3c · Cited by 173
Streit, W. J., & Kincaid-Colton, C. A. (1995) · Scientific American · doi:10.1038/scientificamerican1195-54 · Cited by 171
The contribution of astrocyte signalling to neurovascular coupling
Carmignoto, G., & Gómez-Gonzalo, M. (2010) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.11.007 · Cited by 171
Mogi, M., Harada, M., Kondo, T., Narabayashi, H., Riederer, P., & Nagatsu, T. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11686-q · Cited by 165
Ubhi, K., Rockenstein, E., Mante, M., Inglis, C., Adame, A., Patrick, C., Whitney, K., & Masliah, E. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0567-10.2010 · Cited by 147
Mutant α-Synuclein Overexpression Mediates Early Proinflammatory Activity
Su, X., Federoff, H. J., & Maguire-Zeiss, K. A. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9053-x · Cited by 145
Glial Cells as Players in Parkinsonism: The “Good,” the “Bad,” and the “Mysterious” Glia
Mena, M. A., & de Yébenes, J. G. (2008) · The Neuroscientist · doi:10.1177/1073858408322839 · Cited by 143
Stypuła, G., Radek, M., Stepien, H., Żylińska, K., & Pawlikowski, M. (1996) · NeuroImmunoModulation · doi:10.1159/000097237 · Cited by 134
Maetzler, W., Berg, D., Schalamberidze, N., Melms, A., Schott, K. J., Mueller, J. C., Liaw, L., Gasser, T., & Nitsch, C. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.10.020 · Cited by 131
Nitrated Alpha-Synuclein and Microglial Neuroregulatory Activities
Reynolds, A. D., Kadiu, I., Garg, S. K., Glanzer, J. G., Nordgren, T. M., Ciborowski, P. S., Banerjee, R. V., & Gendelman, H. E. (2008) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-008-9100-z · Cited by 130
Reduced striatal tyrosine hydroxylase in incidental Lewy body disease
Beach, T. G., Adler, C. H., Sue, L. I., Peirce, J. B., Bachalakuri, J., Dalsing-Hernandez, J. E., Lue, L. F., Caviness, J. N., Connor, D. J., Sabbagh, M. N., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-007-0313-7 · Cited by 128
Circulating interleukin-15 and RANTES chemokine in Parkinson’s disease
Rentzos, M., Nikolaou, C., Andreadou, E., Paraskevas, G. P., Rombos, A., Zoga, M., Tsoutsou, A., Boufidou, F., Kapaki, E., & Vassilopoulos, D. (2007) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2007.00894.x · Cited by 123
Carson, M. J., Bilousova, T. V., Puntambekar, S. S., Melchior, B., Doose, J. M., & Ethell, I. M. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2007.07.002 · Cited by 118
Astrocytes and Synaptic Plasticity
Barker, A. J., & Ullian, E. M. (2010) · The Neuroscientist · doi:10.1177/1073858409339215 · Cited by 115
Midbrain neuropathology in idiopathic Parkinson's disease and diffuse Lewy body disease
Halliday, G. M., McRitchie, D. A., Cartwright, H., Pamphlett, R., Hely, M. A., & Morris, J. G. (1996) · Journal of Clinical Neuroscience · doi:10.1016/s0967-5868(96)90083-1 · Cited by 115
Self-citationHardy, J. (2005) · Biochemical Society Transactions · doi:10.1042/bst0330578 · Cited by 105
Mogi, M., Harada, M., Kondo, T., Riederer, P. F., & Nagatsu, T. (1995) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02252965 · Cited by 105
Soulet, D., & Rivest, S. (2008) · Current Biology · doi:10.1016/j.cub.2008.04.047 · Cited by 97
Astrocyte, the star avatar: redefined
Seth, P., & Koul, N. (2008) · Journal of Biosciences · doi:10.1007/s12038-008-0060-5 · Cited by 96
Sasaki, K., Doh‐ura, K., Wakisaka, Y., & Iwaki, T. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0546-4 · Cited by 93
Ledesma, M. D., Galván, C. A., Hellias, B., Dotti, C. G., & Jensen, P. H. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01253.x · Cited by 90
Interleukin-2 but not basic fibroblast growth factor is elevated in parkinsonian brain
Mogi, M., Harada, M., Kondo, T., Riederer, P. F., & Nagatsu, T. (1996) · Journal of Neural Transmission · doi:10.1007/bf01291792 · Cited by 90
Arai, T., Uéda, K., Ikeda, K., Akiyama, H., Haga, C., Kondo, H., Kuroki, N., Niizato, K., Iritani, S., & Tsuchiya, K. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00890-8 · Cited by 85
DnaJB6 is present in the core of Lewy bodies and is highly up‐regulated in parkinsonian astrocytes
Durrenberger, P. F., Filiou, M. D., Moran, L. B., Michael, G. J., Novoselov, S. S., Cheetham, M. E., Clark, P., Pearce, R. K. B., & Graeber, M. B. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21819 · Cited by 76
The COX-2 inhibitor parecoxib produces neuroprotective effects in MPTP-lesioned rats
Reksidler, A. B., Lima, M. M. S., Zanata, S. M., Machado, H. B., Cunha, C. D., Andreatini, R., Tufik, S., & Vital, M. A. B. F. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.12.032 · Cited by 75
Nonselenium Glutathione Peroxidase in Human Brain
Power, J. H. T., Shannon, J. M., Blumbergs, P. C., & Gai, W. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64249-6 · Cited by 70
Hurley, S. D., O’Banion, M. K., Song, D. D., Arana, F. S., Olschowka, J. A., & Haber, S. N. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00273-5 · Cited by 68
COX-2-deficient mice are less prone to MPTP-neurotoxicity than wild-type mice
Feng, Z., Li, D., Fung, P. C. W., Pei, Z., Ramsden, D. B., & Ho, S. (2003) · Neuroreport · doi:10.1097/00001756-200310270-00009 · Cited by 65
α-Synuclein pathology in the neostriatum in Parkinson’s disease
Mori, F., Tanji, K., Zhang, H., Kakita, A., Takahashi, H., & Wakabayashi, K. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0316-4 · Cited by 61
DJ‐1 immunoreactivity in human brain astrocytes is dependent on infarct presence and infarct age
Mullett, S., Hamilton, R. L., & Hinkle, D. (2009) · Neuropathology (Kyoto. 1993) · doi:10.1111/j.1440-1789.2008.00955.x · Cited by 57
Zarate-Lagunes, M., Gu, W., Blanchard, V., François, C., Muriel, M., Prigent, A., Bonici, B., Parent, A., Hartmann, A., Yelnik, J., et al. (2001) · The Journal of Comparative Neurology · doi:10.1002/cne.1096 · Cited by 49
LRRK2 and parkin immunoreactivity in multiple system atrophy inclusions
Huang, Y. M., Song, Y. J. C., Murphy, K., Holton, J. L., Lashley, T., Révész, T., Gai, W., & Halliday, G. M. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0446-3 · Cited by 48
Self-citationAutoimmune Encephalomyelitis and Uveitis Induced by T Cell Immunity to Self β-Synuclein
Mor, F., Quintana, F. J., Mimran, A., & Cohen, I. R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.628 · Cited by 43
Expression of glucose transporter 5 by microglia in human gliomas
Sasaki, A., Yamaguchi, H., Horikoshi, Y., Tanaka, G., & Nakazato, Y. (2004) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2004.00556.x · Cited by 42
Barres, B. A. (2003) · Glia · doi:10.1002/glia.10252 · Cited by 41
Damage to oligodendrocytes in the striatum after MPTP neurotoxicity in mice
Takagi, S., Hayakawa, N., Kimoto, H., Kato, H., & Araki, T. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-007-0790-9 · Cited by 41
Differential Expression of Apolipoprotein D in Human Astroglial and Oligodendroglial Cells
Navarro, A., del Valle, E., & Tolivia, J. (2004) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.3a6213.2004 · Cited by 41
β‐Synuclein occurs in vivo in lipid‐associated oligomers and forms hetero‐oligomers with α‐synuclein
Israeli, E., & Sharon, R. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05776.x · Cited by 40
Apolipoprotein D Expression in Human Brain Reactive Astrocytes
del Valle, E., Navarro, A., Astudillo, A., & Tolivia, J. (2003) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540305101005 · Cited by 39
Sterols in the central nervous system
Mulder, M. T. (2009) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32832182da · Cited by 37
Expression of β-synuclein in normal human astrocytes
Tanji, K., Mori, F., Nakajo, S., Imaizumi, T., Yoshida, H., Hirabayashi, T., Yoshimoto, M., Satoh, K., Takahashi, H., & Wakabayashi, K. (2001) · Neuroreport · doi:10.1097/00001756-200109170-00018 · Cited by 25
Evidence against a reliable staging system of α‐synuclein pathology in Parkinson's disease
Kalaitzakis, M. E., Graeber, M. B., Gentleman, S., & Pearce, R. K. B. (2009) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.00998.x · Cited by 19
Bodega, G., Suárez, I., López-Fernández, L. A., Almonacid, L., Zaballos, Á., & Fernández, B. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2005.12.014 · Cited by 18
Research works printed but not linked: 1
- Braak H, 2009, Neuroanatomy and pathology of sporadic Parkinson's disease
Cited by
Microglia in neurodegeneration
Hickman, S., Izzy, S., Sen, P., Morsett, L., & El Khoury, J. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0242-x · Cited by 1,710
Toll‐like receptor 4 is required for α‐synuclein dependent activation of microglia and astroglia
Fellner, L., Irschick, R., Schanda, K., Reindl, M., Klimaschewski, L., Poewe, W., Wenning, G. K., & Stefanova, N. (2013) · Glia · doi:10.1002/glia.22437 · Cited by 697
Metabolism and functions of copper in brain
Scheiber, I. F., Mercer, J. F. B., & Dringen, R. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.01.002 · Cited by 506
Sex differences in Parkinson’s disease
Gillies, G. E., Pienaar, I. S., Vohra, S., & Qamhawi, Z. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.02.002 · Cited by 489
Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts
Jellinger, K. A. (2012) · Movement Disorders · doi:10.1002/mds.23795 · Cited by 451
Metadata
- Authors
- Halliday, G. M., & Stevens, C. H.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2011-01
- Volume
- 26
- Issue
- 1
- Pages
- 6-17
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W1990195639
- Cited by
- 424
- References
- 136
- FWCI
- 20.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.